Respiratory Medication Articles & Analysis
20 news found
We are happy to announce that the #simeox device is now commercially available in Canada. Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. ...
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). ...
ByFluidda
The initial targeted indications include: Post-operative Respiratory Depression. Respiratory depression is common in patients recovering from surgery and anesthesia. ...
Oxygen is a life-saving therapeutic gas, which is often used to treat patients with severe pneumonia and other respiratory diseases. Oxygen generator is an electric medical equipment. It first inhales air, removes nitrogen, then generates a continuous oxygen source, and delivers concentrated oxygen to patients who need respiratory support in a ...
(VIDA), the leader in lung and respiratory intelligence, has received market authorization in Japan for its VIDA Insights® software, paving the way for lung care teams to begin using the solution at the point of care. Clairvo Technologies, Inc., a wholly owned subsidiary of Marubeni Corporation, secured the certification from Japan’s Pharmaceuticals and ...
Their team’s clinical, fundraising and business development experience will help Stemedica advance our best-in-class stem cell technology to treat those with medical conditions resulting from COVID-19 or other pulmonary indications targeted by Pulthera.” Pulthera, a Delaware Incorporated Limited Liability Corporation, was formed for the express purpose of advancing ...
Quasar Medical Devices, LLC is pleased to announce the expansion of our North American Commercial Headquarters in Minnetonka, Minnesota. This expansion strengthens Quasar’s global presence, allowing for a continued focus on supporting North American customers. Located in one of the key medical device clusters, Quasar Medical Devices USA ...
Using the MediPines AGM100®, a respiratory medical device,researchers were able to demonstrate that the new breath-based measurement of gas exchange efficiency has very low variability and is highly correlated with established blood-sampling methods. ...
It allows for medical professionals to rapidly assess the respiratory status of a patient, titrate interventions, and determine response to therapy. ...
Northern Ireland headquartered Eakin Healthcare Group has announced it is expanding into a new therapeutic area with the acquisition of Coleraine based Armstrong Medical, which specialises in respiratory care products. The deal represents a diversification for the Group which to date has specialised in ostomy and wound care products. ...
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today ...
“Bringing together two companies’ expertise and strengths, we believe we can further contribute to patients’ QOL by providing a solution to an unmet medical need in the respiratory field.” “LTI-01 has the potential to be the first and only approved therapeutic for loculated pleural effusion patients,” stated Brian Windsor, CEO ...
To meet this growing challenge in the face of rising pandemic, MediPines, a respiratory medical device company, has released a scientific paper on respiratory monitoring in long-term care facilities. ...
Launched in July of 2020, this challenge aims to foster collaboration between medical and technology providers to improve the delivery of healthcare in Georgia. ...
N8 Medical, LLC, a privately held biotechnology company, today announced that its CeraShield™ coated endotracheal tubes significantly reduced the growth of COVID-19 virus in recent testing. ...
MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the “Make Your Medical Device Pitch for ...
On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal system), respiratory dynamics (respiratory neuromuscular stimulator), and cuff pressure gauge (balloon manometers). All these innovating devices will be donated to ...
Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic ...
ByKoura
Stavros Garantziotis, M.D., a principal investigator in the Laboratory of Respiratory Biology (LRB) and the medical director for the CRU, is a co-author on the article. ...
Stavros Garantziotis, M.D., a principal investigator in the Laboratory of Respiratory Biology (LRB) and the medical director for the CRU, is a co-author on the article. ...